Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets respond to government's TB control strategy
The BCVA has objected to plans that recently-issued badger control licenses could drop from four years to two.

Plans suggest that intensive culling could end after 2022.

The British Cattle Veterinary Association (BCVA) has responded to government plans to tackle bovine tuberculosis (bTB) in England.

On Thursday (28 May), Defra announced a raft of new measures to eradicate the disease in England by 2038, including work on badger vaccination, increased cattle testing and the acceleration of a cattle vaccine.

The plans, which follow an eight-week consultation, also suggest that licensing of new intensive culls will end after 2022, and that existing cull licenses could be cut short after two years.

In a statement, BCVA welcomed some of the control measures but expressed concern over plans to cease the issuing of new licences.

“We were pleased that some of the planned measures are in line with our recently published bTB document and consultation responses, and we can broadly support some of the proposals during this consultation,” the organisation said. “However, in our consultation response, we cited serious concerns surrounding the lack of significant evidence to support a change to the current wildlife control strategy.

“BCVA illustrated how several proposals could cause disruption to ongoing trials, or even cause regression in the progress that has been made to reduce incidents of bTB on farms throughout the UK, inflicting further hardship on the farming industry, who are already crushed by the impact of this devastating disease."

It continued: “A strategy with proven efficacy could unravel, with regressive results and serious loss of engagement within the farming industry. Consequently, BCVA has serious objections to the proposal that recently issued licences could drop from four years to just two years.”

Under the new plans, Defra also announced funding for a five-year badger vaccination pilot in East Sussex to enable farmers to deploy vaccinations over an area of 250 square kilometres.

The BCVA writes: “BCVA of course supports evidence gathering for large scale, farmer-led vaccination and accepts the Government’s intention to pilot badger vaccination in an area where the four-year cull cycle has concluded. This would be on the basis that there is simultaneous surveillance of disease and data collection to review vaccine efficacy.

“BCVA is not alone in calling on the government to further develop the evidence base for badger vaccination before seeking to remove the option of badger culling, warning that areas may lose the option of supplementary badger culling (SBC) before this can be developed.”

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.